Home/Investors/Roche Venture Fund

Roche Venture Fund

Biotech Investor · 3 portfolio companies

Portfolio

3

Focus Areas

7

Top Stage

Phase 2

Investment Focus

Autoimmune Diseases Celiac Disease Multiple Sclerosis Ophthalmology Genetic Diseases Metabolic Diseases Oncology

Portfolio Companies

Company	Stage	Valuation	Focus
Anokion	Phase 2	—	Autoimmune Diseases, Celiac Disease
SpliceBio	Phase 1	—	Ophthalmology, Genetic Diseases
NGM Bio	phase-2	—	Metabolic Diseases, Oncology

Frequent Co-Investors

Versant Ventures1 shared The Column Group1 shared Novo Holdings1 shared Ysios Capital1 shared Sanofi Ventures1 shared New Enterprise Associates1 shared Novartis Venture Fund1 shared UCB Ventures1 shared